EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unraveling the NLRP family: Structure, function, activation, critical influence on tumor progression, and potential as targets for cancer therapy

Xueqing Zhou, Yongguang Tao, Ying Shi

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217283 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024. Verfasst von Xueqing Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South Univ…. Hauptthemen laut MEDLINE: Neoplasms, Disease Progression. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 211 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The innate immune system serves as the body's initial defense, swiftly detecting danger via pattern recognition receptors (PRRs). Among these, nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing proteins (NLRPs) are pivotal in recognizing pathogen-associated and damage-associated molecular patterns, thereby triggering immune responses. NLRPs, the most extensively studied subset within the NLR family, form inflammasomes that regulate inflammation, essential for innate immunity activation. Recent research highlights NLRPs' significant impact on various human diseases, including cancer. With differential expression across organs, NLRPs influence cancer progression by modulating immune reactions, cell fate, and proliferation. Their clinical significance in cancer makes them promising therapeutic targets. This review provides a comprehensive overview of the structure, function, activation mechanism of the NLRPs family and its potential role in cancer progression. In addition, we particularly focused on the concept of NLRP as a therapeutic target and its potential value in combination with immune checkpoint inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDisease ProgressionHumansInflammasomesNLR ProteinsImmunity, InnateAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

CancerImmunityNLRP inflammasomeNLRP3NLRP3 inhibitors

Substanzen

InflammasomesNLR Proteins

Autor:innen und Institutionen

  • Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, 410013, China; Cancer Research Institute and…

Förderung

  • Hunan Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, X., Tao, Y., & Shi, Y. (2024). Unraveling the NLRP family: Structure, function, activation, critical influence on tumor progression, and potential as targets for cancer therapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217283

Vancouver

Zhou X, Tao Y, Shi Y. Unraveling the NLRP family: Structure, function, activation, critical influence on tumor progression, and potential as targets for cancer therapy. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217283

BibTeX
@article{Zhou2024,
  author = {Zhou, Xueqing and Tao, Yongguang and Shi, Ying},
  title = {Unraveling the NLRP family: Structure, function, activation, critical influence on tumor progression, and potential as targets for cancer therapy},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217283}
}
Kostenlos starten →